Pricing Log in Create free account

Alzamend Neuro, Inc. (ALZN) vs CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN)

Alzamend Neuro, Inc. and CollPlant Biotechnologies Ltd. Sponsored ADR are both Biotechnology companies. Alzamend Neuro, Inc. and CollPlant Biotechnologies Ltd. Sponsored ADR are of similar size ($7.5M and $7.5M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Alzamend Neuro, Inc. leads on 10 and CollPlant Biotechnologies Ltd. Sponsored ADR on 2.

Valuation

Metric ALZN CLGN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 18.24 9.18
P/B 1.18 1.97 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.05 n/m 0.65
EV/Sales n/m 26.12 8.98
Earnings yield (150.33%) (235.64%) (34.89%)
Free cash flow yield (104.25%) (193.83%) (24.52%)

Profitability

Metric ALZN CLGN Biotechnology median
Gross margin 0.00% (321.70%) 65.16%
Operating margin 0.00% (3,900.94%) 0.00%
Net margin 0.00% (3,934.91%) 0.00%
Free cash flow margin 0.00% (3,522.64%) 0.00%
Return on equity (163.23%) (161.98%) (50.12%)
Return on assets (122.36%) (101.59%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALZN CLGN Biotechnology median
Revenue growth (TTM) — (86.76%) 6.26%
EPS growth (last fiscal year) 76.77% 35.17% 29.88%
Revenue growth, 5-year CAGR — (17.32%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALZN CLGN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.01 1.57 4.89
Net debt to EBITDA 0.08 0.56 1.01

Dividend

Metric ALZN CLGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALZN CLGN Biotechnology median
Market cap 7.48m 7.45m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack